Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc C Chamberlain

Showing results (181-190 of 244) with videos related to

Pageof 25
Sort By:
Expert Review of Neurotherapeutics|April 18, 2008
Anaplastic astrocytomas: biology and treatmentMarc C Chamberlain, Sajeel A Chowdhary, Michael J Glantz
Neurology|April 14, 2010
Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastomaMarc C Chamberlain, Andrew B Lassman, Fabio M Iwamoto
Journal of Neuro-Oncology|April 22, 2006
Salvage chemotherapy with CPT-11 for recurrent meningiomaMarc C Chamberlain, Denice D Tsao-Wei, Susan Groshen
Cancer|December 3, 2005
Salvage chemotherapy with cyclophosphamide for recurrent temozolomide-refractory anaplastic astrocytomaMarc C Chamberlain, Denice D Tsao-Wei, Susan Groshen
Neurology|September 6, 2007
Recurrent meningioma: salvage therapy with long-acting somatostatin analogueMarc C Chamberlain, Michael J Glantz, Camilo E Fadul
Neurology|April 14, 2004
Temozolomide for treatment-resistant recurrent meningiomaMarc C Chamberlain, Denice D Tsao-Wei, Susan Groshen
Archives of Neurology|January 14, 2009
Neoplastic meningitis-related prognostic significance of the Karnofsky performance statusMarc C Chamberlain, Sandra K Johnston, Mike J Glantz
Neurology|September 11, 2013
Teaching NeuroImages: sacral spine chloromaMarc C Chamberlain, Trent L Tredway, Donald Born, et al.
Neurology|July 21, 2010
Optic neuropathy in patients with glioblastoma receiving bevacizumabMarc C Chamberlain, Jeffrey Raizer, David Schiff, et al.
Journal of Neuro-Oncology|February 17, 2017
Salvage therapy with bendamustine for temozolomide refractory recurrent anaplastic gliomas: a prospective phase II trialMarc C Chamberlain, Howard Colman, Bryan T Kim, et al.
Pageof 25

Showing results (181-190 of 244) with videos related to

Sort By:
Pageof 25
Expert Review of Neurotherapeutics|April 18, 2008
Anaplastic astrocytomas: biology and treatmentMarc C Chamberlain, Sajeel A Chowdhary, Michael J Glantz
Neurology|April 14, 2010
Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastomaMarc C Chamberlain, Andrew B Lassman, Fabio M Iwamoto
Journal of Neuro-Oncology|April 22, 2006
Salvage chemotherapy with CPT-11 for recurrent meningiomaMarc C Chamberlain, Denice D Tsao-Wei, Susan Groshen
Cancer|December 3, 2005
Salvage chemotherapy with cyclophosphamide for recurrent temozolomide-refractory anaplastic astrocytomaMarc C Chamberlain, Denice D Tsao-Wei, Susan Groshen
Neurology|September 6, 2007
Recurrent meningioma: salvage therapy with long-acting somatostatin analogueMarc C Chamberlain, Michael J Glantz, Camilo E Fadul
Neurology|April 14, 2004
Temozolomide for treatment-resistant recurrent meningiomaMarc C Chamberlain, Denice D Tsao-Wei, Susan Groshen
Archives of Neurology|January 14, 2009
Neoplastic meningitis-related prognostic significance of the Karnofsky performance statusMarc C Chamberlain, Sandra K Johnston, Mike J Glantz
Neurology|September 11, 2013
Teaching NeuroImages: sacral spine chloromaMarc C Chamberlain, Trent L Tredway, Donald Born, et al.
Neurology|July 21, 2010
Optic neuropathy in patients with glioblastoma receiving bevacizumabMarc C Chamberlain, Jeffrey Raizer, David Schiff, et al.
Journal of Neuro-Oncology|February 17, 2017
Salvage therapy with bendamustine for temozolomide refractory recurrent anaplastic gliomas: a prospective phase II trialMarc C Chamberlain, Howard Colman, Bryan T Kim, et al.
Pageof 25